R. M. Moslin et al. / Tetrahedron 62 (2006) 7598–7610
7609
1.0 mmol) in the presence of Ni(cod)2 (14 mg, 0.05 mmol),
PBu3 (25 mL, 0.1 mmol), and Et3B (0.15 mL, 1.0 mmol).
Crude material was chromatographed with 15:1 hexanes/
diethyl ether/9:1 hexanes/ethyl acetate to give 15.6 mg
(13%) of 30A and 14.8 mg (12%) of 30B as clear oils
(30A: 45:55 mixture of diastereomers; 30B: 42:58 mixture
of diastereomers).
to give 82 mg (78%) of 37 as a single regioisomer and as
a mixture of diastereomers (91:1 R, R, to R, S). Rf¼0.48
(6:1 hexanes/EtOAc, KMnO4) [a]2D2 ꢂ0.45 (c 0.84, DCM);
IR 3391 (b, m), 2959 (s), 2922 (s), 2872 (s), 1640 (w),
1460 (m), 1121 (w), 1010 (s), 911 (s) cmꢂ1 1H NMR
;
(500 MHz, CDCl3)—data are for (R,R) diastereomer—
d 5.52 (ddd, J¼17.0, 10.0, 9.0 Hz, 1H), 5.34 (t, J¼7.0 Hz,
1H), 5.00 (dd, J¼10.0, 2.0 Hz, 1H), 4.95 (dd, J¼17.0,
2.0 Hz, 1H), 3.57 (dd, J¼9.0, 3.0 Hz, 1H), 2.01 (m, 2H),
1.86 (m, 1H), 1.76 (m, 1H), 1.58 (s, 3H), 1.43 (m, 2H),
1.39 (OH) (d, J¼3.0 Hz, 1H), 1.28 (m, 2H), 0.99 (d,
J¼7.0 Hz, 3H), 0.85 (t, J¼7.0 Hz, 3H), 0.78 (d, J¼7.0 Hz,
3H); 13C NMR (125.8 MHz, CDCl3) d 143.1, 136.5, 128.2,
114.8, 84.5, 45.7, 34.6, 31.3, 28.0, 25.4, 19.7, 18.9, 11.9,
11.4.
Compound 30A: IR 3411 (b, m), 2962 (s), 2956 (s), 2872 (s),
2870 (s), 2361 (w), 1465 (m), 1363 (s), 1016 (b, s), 925
1
(s) cmꢂ1; H NMR (500 MHz, CDCl3)—data are for (ꢃ)-
(R,R) diastereomer—d 5.72 (ddd, J¼17.5, 10.0, 8.5 Hz,
1H), 5.52 (t, J¼6.0 Hz, 1H), 5.25 (dd, J¼10.0, 1.5 Hz,
1H), 5.14 (dd, J¼17.5, 1.5 Hz, 1H), 4.08 (dd, J¼12.5,
6.0 Hz, 1H), 3.86 (dd, J¼12.5 Hz, 7.0 Hz, 1H), 3.64 (dd,
J¼8.5, 3.0 Hz, 1H), 3.21 (d, J¼8.5 Hz, 1H), 1.78 (apparent
hex, J¼7.0 Hz, 1H), 1.60 (s, 3H), 1.54 (OH) (d, J¼3.0 Hz,
1H), 0.99 (d, J¼7.0 Hz, 3H), 0.88 (s, 9H), 0.82 (d,
J¼7.0 Hz, 3H); 13C NMR (125.8 MHz, CDCl3) d 140.3,
139.3, 124.5, 117.2, 83.6, 82.4, 64.5, 31.0, 28.5, 19.6,
18.5, 11.9, 10.0; HRMS m/z (ESI, M+Na+) calcd 263.1982
found 263.1982.
The (R,S) diastereomer was not independently synthesized;
however, those peaks which were resolvable from the
(R,R) diastereomer were 1H NMR (500 MHz, CDCl3)
d 5.56 (ddd, J¼17.0, 10.0, 9.0 Hz, 1H), 4.10 (dd, J¼9.0,
3.0 Hz, 1H), 1.07 (d, J¼6.0 Hz, 3H), 0.72 (d, J¼6.0 Hz, 3H).
4.3.2.17. (+)-Aceticacid 1-isopropyl-2-oxo-propyl ester
((+)-32).
The (ꢃ)-(R,S) diastereomer was not independently synthe-
sized; however, those peaks that were resolvable from the
(ꢃ)-(R,R) diastereomer were H NMR (500 MHz, CDCl3)
O
1
iPr
Me
d 4.05 (dd, J¼12.5, 5.5 Hz, 1H), 3.23 (d, J¼8.5 Hz, 1H),
0.97 (d, J¼6.5 Hz, 3H), 0.89 (s, 9H).
OAc
32
Compound 30B: IR 3462 (b, m), 2956 (s), 2870 (s), 2361
(w), 1670 (b, w), 1465 (m), 1364 (m), 1068 (s) cmꢂ1; the
diastereomers were not separated, peaks belonging to a spe-
cific diastereomer are indicated by subscript A or B, with
achiral phosphines A was the major product. 1H NMR
(500 MHz, CDCl3) d 5.72 (m, 1H), 5.61 (apparent q,
J¼6.5 Hz, 1H), 5.32A (dd, J¼10.5, 2.0 Hz, 1H), 5.31B (dd,
J¼10.5, 2.0 Hz, 1H), 5.21 (d, J¼17.5 Hz, 1H), 4.29B
(d, J¼11.0 Hz, 1H), 4.08A (d, J¼11.0 Hz, 1H), 3.94A (d,
J¼11.0 Hz, 1H), 3.74B (d, J¼11.0 Hz, 1H), 3.56 (q, J¼
7.0 Hz, 1H), 3.27B (d, J¼8.0 Hz, 1H), 3.23A (d, J¼8.0 Hz,
1H), 2.85B (OH) (d, J¼7.0 Hz, 1H), 2.82A (OH) (d,
J¼7.0 Hz, 1H), 1.80 (m, 1H), 1.66 (m, 3H), 1.63 (M, 1H),
1.03 (apparent t, J¼6.5 Hz, 3H), 0.90B (s, 9H), 0.89A
(s, 9H), 0.76 (apparent t, J¼6.0 Hz, 3H); no attempt was
made to specify which carbon signals belonged to each dia-
stereomer, there are exactly double the number of expected
signals for a single compound. 13C NMR (125.8 MHz,
CDCl3) d 137.3, 137.1, 135.9, 135.8, 126.8, 126.7, 119.5,
119.3, 90.6, 90.6, 84.4, 84.3, 65.0, 64.8, 34.6, 34.6, 32.5,
32.4, 26.4, 26.3, 19.9, 19.8, 19.3, 19.3, 13.4, 13.4; HRMS
m/z (ESI, M+Na+) calcd 263.1982 found 263.1986.
To a cold (0 ꢀC) solution of (ꢂ)-29A (35 mg, 0.165 mmol) in
DCM (1.5 ml) was added NEt3 (71 mL, 0.51 mmol), Ac2O
(24 mL, 0.25 mmol), and DMAP (2 mg, 0.016 mmol). The
mixture was warmed to room temperature and stirred for
1.5 h. At this point it was concentrated in vacuo and filtered
through silica eluting with 10:1 hexanes/ethyl acetate. This
afforded the crude acetate-protected product, which was
carried on to the ozonolysis without purification. The inter-
mediate was dissolved in DCM (3 mL) cooled to ꢂ78 ꢀC
and exposed to O3 until the reaction was dark blue. The
solution was then degassed with argon and PPh3 (600 mg)
was added. The reaction was allowed to warm to 0 ꢀC over
4 h, and then concentrated in vacuo. The crude material was
loaded onto a column (15:1 pentanes/DCM) with a minimal
amount of DCM and then eluted with 15:1 pentanes/DCM
until separation of PPh3 and byproducts was complete,
then column was flushed with 1:1 pentanes/diethyl ether to
give (+)-32 as a clear oil (15.1 mg, 58% over two steps).
1
[a]2D2 +6.7 (c 1.01, DCM); H NMR (500 MHz, CDCl3)
d 4.87 (d, J¼4.0 Hz, 1H), 2.24 (m, 1H), 2.17 (s, 3H), 2.16
(s, 3H), 1.01 (d, J¼7.0 Hz, 3H), 0.93 (d, J¼7.0 Hz, 3H);
13C NMR (125.8 MHz, CDCl3) d 205.6, 171.0, 83.0, 29.6,
27.2, 20.8, 19.4, 17.0.
4.3.2.16. 8-Ethyl-2,4-dimethyl-deca-4,9-dien-3-ol (37).
Compound (+)-32: Following the above procedure, 37
(42 mg, 0.2 mmol) was converted to (+)-32 (20.5 mg,
66%) over two steps. [a]2D2 +7.7 (c 1.4, DCM).
OH
iPr
Et
Me
37
Procedure A (no additive) (no EtOAc): 33 (68 mg,
0.5 mmol) was reacted with i-PrCHO (90 mL, 1.0 mmol) in
the presence of Ni(cod)2 (14 mg, 0.05 mmol) and Et3B
(0.15 mL, 1.0 mmol). Crude material was chromatographed
with 15:1 hexanes/diethyl ether/8:1 hexanes/ethyl acetate
Acknowledgements
This work was supported by the National Institute of General
Medical Science (GM-063755). We thank Dr. Li Li (MIT
Department of Chemistry Instrumentation Facility) for